Zhu X R, Netzer R, Böhlke K, Liu Q, Pongs O
Institut für neurale Signalverarbeitung, Zentrum für molekulare Neurobiologie Hamburg, Germany.
Recept Channels. 1999;6(5):337-50.
We have cloned and functionally expressed Kv6.2, a new member of the Kv6 subfamily of voltage-gated potassium channel subunits. The human Kv6.2 (KCNF2) gene was mapped at 18q22-18q23. Kv6.2 mRNA is preferentially expressed in rat and human myocard. Rat and human Kv6.2 subunits appear to be unable to form functional Kv channels in a heterologous expression system, but, when coexpressed with Kv2.1 alpha subunits, heteromultimeric Kv channels were formed mediating voltage-activated delayed-rectifier type outward currents. Their kinetics and conductance-voltage relationship were different from those mediated by homomultimeric Kv2.1 channels. Yeast two-hybrid reporter assays indicated that Kv6.2 amino-termini are able to interact specifically with the Kv2.1 amino-terminus. It is proposed that this protein protein interaction underlies Kv2.1/Kv6.2 subunit assembly and the expression of functional heteromultimeric Kv2.1/Kv6.2 channels. The most resiliant feature of the Kv2.1/Kv6.2 channels was their submicromolar sensitivity to the antiarrhythmic drug propafenone. The data suggest that delayed-rectifier type channels containing Kv6.2 subunits may contribute to cardiac action potential repolarization.
我们已经克隆并功能性表达了电压门控钾通道亚基Kv6亚家族的一个新成员Kv6.2。人类Kv6.2(KCNF2)基因定位于18q22 - 18q23。Kv6.2 mRNA在大鼠和人类心肌中优先表达。在异源表达系统中,大鼠和人类Kv6.2亚基似乎无法形成功能性Kv通道,但是,当与Kv2.1α亚基共表达时,会形成异源多聚体Kv通道,介导电压激活的延迟整流型外向电流。它们的动力学和电导 - 电压关系与同源多聚体Kv2.1通道介导的不同。酵母双杂交报告基因检测表明,Kv6.2的氨基末端能够与Kv2.1的氨基末端特异性相互作用。有人提出,这种蛋白质 - 蛋白质相互作用是Kv2.1 / Kv6.2亚基组装以及功能性异源多聚体Kv2.1 / Kv6.2通道表达的基础。Kv2.1 / Kv6.2通道最显著的特征是它们对抗心律失常药物普罗帕酮具有亚微摩尔级的敏感性。数据表明,含有Kv6.2亚基的延迟整流型通道可能有助于心脏动作电位的复极化。